Amgen’s FDA-approved Avsola (infliximab-axxq) is a medication used to treat a variety of autoimmune conditions, including Crohn's disease, ulcerative colitis, rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. It works by targeting specific proteins in the immune system that contribute to inflammation.
Avsola is given as an intravenous infusion in a healthcare setting. The dosing frequency and amount of medication will depend on the patient's condition and response to treatment.
However, as a healthcare provider, obtaining access to Avsola enrollment forms can be time-consuming and confusing. In this article, we will provide you with access to Avsola enrollment forms and introduce you to the Amgen Assist® Program – which provides a variety of HCP and patient resources to streamline the process of prescribing Avsola to treat patients.